Evaluation of Analgesic Effect of Equimolar Mixture of Oxygen and Nitrous Oxide Inhalation During Percutaneous Biopsy of Focal Liver Lesions: A Double-blind Randomized Study

被引:13
|
作者
Meskine, Nawel [1 ]
Vullierme, Marie-Pierre [1 ]
Zappa, Magaly [1 ]
d'Assignies, Gaspard [1 ,2 ,3 ]
Sibert, Annie [1 ]
Vilgrain, Valerie [1 ,2 ,3 ]
机构
[1] Hop Beaujon, AP HP, Dept Radiol, F-92110 Clichy, France
[2] Univ Paris 07, Paris, France
[3] Ctr Rech Biomed Bichat Beaujon, INSERM, Paris, France
关键词
Liver biopsy; analgesia; liver biopsy; pain; liver neoplasms; biopsy; DIAGNOSIS; MANAGEMENT;
D O I
10.1016/j.acra.2011.01.025
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: Percutaneous liver biopsy for tumors performed under local anesthesia is still a painful procedure. The aim of this study was to evaluate the patient's reaction and the analgesic efficacy and safety of an equimolar mixture of oxygen and nitrous oxide (EMONO) inhalation. Materials and Methods: A monocenter, prospective, randomized and double-blind controlled study was performed including 99 adult patients undergoing ultrasound controlled liver biopsy for tumors. 50 patients received an EMONO and 49 patients received a placebo. Pain was evaluated by patients before and after the procedure using a Visual Analog Scale. Results: Analgesic control, defined by the difference between the final and initial VAS scores (A), was significantly better in the EMONO group than in the placebo group (Delta = 17.8 +/- 25.5 mm vs 30.1 +/- 32.6 mm; P = .045. The number of patients who would agree to undergo another liver biopsy under the same conditions was significantly higher in the EMONO group than the placebo group (92.0% vs 75.5%, P = .026). There were no side-effects from the administration of an EMONO. Conclusion: This study shows that patients receiving an EMONO had a higher analgesic control after percutaneous biopsy of focal liver lesions than patients in the placebo group. Moreover, acceptance of additional biopsies was higher in the EMONO group.
引用
收藏
页码:816 / 821
页数:6
相关论文
共 35 条
  • [31] Periprostatic lidocaine infiltration and/or synthetic opioid (meperidine or tramadol) administration have no analgesic benefit during prostate biopsy - A prospective randomized double-blind placebo-controlled study comparing different methods
    Bozlu, M
    Atici, S
    Ulusoy, E
    Canpolat, B
    Cayan, S
    Akbay, E
    Schellhammer, PF
    Oral, U
    UROLOGIA INTERNATIONALIS, 2004, 72 (04) : 308 - 311
  • [32] A prospective randomized double-blind clinical study to compare the effect of nalbuphine versus fentanyl on attenuation of pressor response during endotracheal intubation and analgesic potential on patients under general anesthesia
    Singh, Maina
    Ali, Naazneen
    Patodi, Veena
    Kumar, Pradeep
    Mathur, Veena
    Khare, Arvind
    INDIAN ANAESTHETISTS FORUM, 2024, 25 (01): : 22 - 28
  • [33] Comparative Evaluation of Analgesic Efficacy of Ultrasound-Guided Pericapsular Nerve Group Block and Femoral Nerve Block During Positioning of Patients With Hip Fractures for Spinal Anesthesia: A Prospective, Double-Blind, Randomized Controlled Study
    Jeevendiran, Annamale
    Suganya, Srinivasan
    Sujatha, Chinthavali
    Rajaraman, Jayashridevi
    Surya, R.
    Asokan, Arthi
    Radhakrishnan, A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [34] Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study
    Jung, Mette Holme
    Hansen, Peter Bo
    Sander, Kaare
    Olsen, Peter Skov
    Rossing, Kasper
    Boesgaard, Soeren
    Russell, Stuart D.
    Gustafsson, Finn
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (04) : 403 - 408
  • [35] Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study
    Joyeux-Faure, Marie
    Durand, Michel
    Bedague, Damien
    Protar, Daniel
    Incagnoli, Pascal
    Paris, Adeline
    Ribuot, Christophe
    Levy, Patrick
    Chavanon, Olivier
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (06) : 761 - 770